Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapy of multiple sclerosis: mitoxantrone]

S Spuler1, R Hohlfeld

  • 1Neurologische Klinik, Klinikum Grosshadern, München.

Der Nervenarzt
|February 1, 1994
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

Journal of neurology·2016
Same author

[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].

Der Nervenarzt·2016
Same author

[Current aspects of therapy conversion for multiple sclerosis].

Der Nervenarzt·2015
Same author

[Immunotherapies for multiple sclerosis : review and update].

Der Internist·2015
Same author

[Neuroinflammatory diseases with a focus on multiple sclerosis - an overview].

Drug research·2013